National Institute of Arthritis and Musculoskeletal and Skin Diseases program recognized for excellence in training, innovation
Gretchen Henkel is an award-winning health and medical journalist based in California. She reports on clinical and outcomes research and practice management issues, as well as patient-centered and culturally competent care for various specialties, including hospital medicine, rheumatology, oncology, otolaryngology and long-term care. As an editorial consultant for the SAMHSA-funded National Child Traumatic Stress Network, she develops content for toolkits on assessment and treatment of childhood abuse and trauma, and is the managing editor of the NCTSN quarterly newsletter, IMPACT.
Articles by Gretchen Henkel
Glucocorticoid Use in Rheumatoid Arthritis Management Focus of Ongoing Debate
Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists
UNC’s Thurston Arthritis Research Center in the Spotlight
Approachability, collaboration foster excellence in this basic science, clinical and epidemiological research program
Osteoimmunology Research May Benefit Patients with Rheumatoid Arthritis
Cross-talk between bone biology, immune system may shed light on joint erosion, refine therapeutic targets for RA
Rheumatologist Lars Klareskog, MD, PhD, In the Spotlight
A career marked by scientific discovery, collaboration
University of California at San Francisco Rheumatology Division Recognized for Excellence
Diversity, depth of department’s clinical and research programs are its hallmarks
Spondyloarthritis: Clues to Earlier Recognition
Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting discuss challenges to diagnosing, managing spondyloarthritides
Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support
Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus
Janus Kinase Inhibitors Represent New Tool to Slow Rheumatoid Arthritis
Physicians at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco report on studies about JAK inhibitors as targeted immunomodulators and disease-modifying therapies in RA
Diagnose, Manage and Treat Giant Cell Arteritis
A rheumatologist at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco shares research findings on this inflammatory blood vessel disease
- « Previous Page
- 1
- …
- 6
- 7
- 8
- 9
- 10
- …
- 14
- Next Page »